Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tarsus Pharmaceuticals Inc shares valued at $1,017,816 were sold by LINK WILLIAM J PHD on Dec 15 ’25. At $81.43 per share, LINK WILLIAM J PHD sold 12,500 shares. The insider’s holdings dropped to 128,832 shares worth approximately $10.02 million following the completion of this transaction.
Also, LINK WILLIAM J PHD sold 10,446 shares, netting a total of over 846,862 in proceeds. Following the sale of shares at $81.07 each, the insider now holds 0 shares.
Before that, Lin Elizabeth Yeu had sold 2,078 shares from its account. In a trade valued at $165,201, the Chief Medical Officer traded Tarsus Pharmaceuticals Inc shares for $79.50 each. Upon closing the transaction, the insider’s holdings decreased to 2,078 shares, worth approximately $1.71 million.
As published in their initiating research note from Barclays on December 09, 2025, Tarsus Pharmaceuticals Inc [TARS] has been an Overweight and the price target has been revised to $100. Analysts at Mizuho started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November.
Analyzing TARS Stock Performance
On last trading session, Tarsus Pharmaceuticals Inc [NASDAQ: TARS] plunged -0.65% to $77.77. The stock’s lowest price that day was $77.63, but it reached a high of $79.77 in the same session. During the last five days, there has been a drop of approximately -4.37%. Over the course of the year, Tarsus Pharmaceuticals Inc shares have jumped approximately 48.13%. Shares of the company reached a 52-week high of $85.25 on 12/09/25 and a 52-week low of $38.51 on 08/01/25.
Support And Resistance Levels for Tarsus Pharmaceuticals Inc (TARS)
According to the 24-hour chart, there is a support level at 77.01, which, if violated, would cause prices to drop to 76.25. In the upper region, resistance lies at 79.15. The next price resistance is at 80.53. RSI (Relative Strength Index) is 49.56 on the 14-day chart, showing neutral technical sentiment.
Is Tarsus Pharmaceuticals Inc subject to short interest?
Stocks of Tarsus Pharmaceuticals Inc saw a sharp steep in short interest on 2025-11-28 dropping by -0.16 million shares to 7.12 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 7.28 million shares. A decline of -2.28% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 15.72 of the overall float, the days-to-cover ratio (short ratio) decline to 15.72.
Which companies own the most shares of Tarsus Pharmaceuticals Inc (TARS)?
In terms of Tarsus Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 94 in the next 12 months, up nearly 20.08% from the previous closing price of $78.28. Analysts anticipate Tarsus Pharmaceuticals Inc stock to reach 100 by 2025, with the lowest price target being 51. In spite of this, 4 analysts ranked Tarsus Pharmaceuticals Inc stock as Buy at the end of 2025. On November 20, 2023, Goldman assigned a price target of “a Neutral” to the stock and initiated coverage with a $19.
